259 related articles for article (PubMed ID: 6629117)
1. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
2. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
[TBL] [Abstract][Full Text] [Related]
3. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Rizzetto M; Purcell RH; Gerin JL
Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
[TBL] [Abstract][Full Text] [Related]
7. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
[TBL] [Abstract][Full Text] [Related]
8. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
9. Fulminant delta hepatitis in chronic hepatitis B infection.
De Cock KM; Govindarajan S; Redeker AG
JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and D virus infection among drug abusers in Taiwan.
Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
[TBL] [Abstract][Full Text] [Related]
11. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
[No Abstract] [Full Text] [Related]
12. Interplay of cell and serum immunologic markers in chronic persistent or active hepatitis B.
Picciotto A; Crovari P; Cuneo Crovari P; De Flora S; Dodero M; Celle G
J Med Virol; 1981; 8(3):195-200. PubMed ID: 7328423
[TBL] [Abstract][Full Text] [Related]
13. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
[TBL] [Abstract][Full Text] [Related]
14. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.
Rizzetto M; Morello C; Mannucci PM; Gocke DJ; Spero JA; Lewis JH; Van Thiel DH; Scaroni C; Peyretti F
J Infect Dis; 1982 Jan; 145(1):18-22. PubMed ID: 7033398
[TBL] [Abstract][Full Text] [Related]
15. [Delta infection in HBsAg carriers].
Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
[TBL] [Abstract][Full Text] [Related]
16. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
Picciotto L; Abrescia N; Ciampi R
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of delta infection.
Moestrup T; Hansson BG; Widell A; Nordenfelt E
Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B and the delta agent].
Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
[No Abstract] [Full Text] [Related]
20. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
